Bronchoscopy Market Research Report by Product (Accessories, Endoscope, and Other), Usability, Application, End-User, Region (Americas, Asia-Pacific, and Europe, Middle East & Africa) - Global Forecast to 2027 - Cumulative Impact of COVID-19

New York, May 24, 2022 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Bronchoscopy Market Research Report by Product, Usability, Application, End-User, Region - Global Forecast to 2027 - Cumulative Impact of COVID-19" - https://www.reportlinker.com/p06276851/?utm_source=GNW The Global Bronchoscopy Market size was estimated at USD 3,298.23 million in 2021 and expected to reach USD 3,626.73 million in 2022, and is projected to grow at a CAGR 10.21% to reach USD 5,911.86 million by 2027. Market Statistics: The report provides market sizing and forecast across five major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF. It helps organization leaders make better decisions when currency exchange data is readily available. In this report, the years 2019 and 2020 are considered historical years, 2021 as the base year, 2022 as the estimated year, and years from 2023 to 2027 are considered the forecast period. Market Segmentation & Coverage: This research report categorizes the Bronchoscopy to forecast the revenues and analyze the trends in each of the following sub-markets: Based on Product, the market was studied across Accessories, Endoscope, Other, and Visualization & Documentation Systems. Based on Usability, the market was studied across Disposable Equipment and Reusable Equipment. Based on Application, the market was studied across Bronchial Diagnosis and Bronchial Treatment. Based on End-User, the market was studied across Ambulatory Surgical Centers & Clinics and Hospitals. Based on Region, the market was studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, and Thailand. The Europe, Middle East & Africa is further studied across France, Germany, Italy, Netherlands, Qatar, Russia, Saudi Arabia, South Africa, Spain, United Arab Emirates, and United Kingdom. Cumulative Impact of COVID-19: COVID-19 is an incomparable global public health emergency that has affected almost every industry, and the long-term effects are projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlying COVID-19 issues and potential paths forward. The report delivers insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the market. Cumulative Impact of 2022 Russia Ukraine Conflict: We continuously monitor and update reports on political and economic uncertainty due to the Russian invasion of Ukraine. Negative impacts are significantly foreseen globally, especially across Eastern Europe, European Union, Eastern & Central Asia, and the United States. This contention has severely affected lives and livelihoods and represents far-reaching disruptions in trade dynamics. The potential effects of ongoing war and uncertainty in Eastern Europe are expected to have an adverse impact on the world economy, with especially long-term harsh effects on Russia.This report uncovers the impact of demand & supply, pricing variants, strategic uptake of vendors, and recommendations for Bronchoscopy market considering the current update on the conflict and its global response. Competitive Strategic Window: The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period. FPNV Positioning Matrix: The FPNV Positioning Matrix evaluates and categorizes the vendors in the Bronchoscopy Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape. Market Share Analysis: The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits. Competitive Scenario: The Competitive Scenario provides an outlook analysis of the various business growth strategies adopted by the vendors. The news covered in this section deliver valuable thoughts at the different stage while keeping up-to-date with the business and engage stakeholders in the economic debate. The competitive scenario represents press releases or news of the companies categorized into Merger & Acquisition, Agreement, Collaboration, & Partnership, New Product Launch & Enhancement, Investment & Funding, and Award, Recognition, & Expansion. All the news collected help vendor to understand the gaps in the marketplace and competitor’s strength and weakness thereby, providing insights to enhance product and service. Company Usability Profiles: The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the Global Bronchoscopy Market, including Ambu A/S, Boston Scientific Corporation, Conmed Corporation, Cook Group Incorporated, EFER Endoscopy, EMOS Technology GmbH, Ethicon, Inc., Fujifilm Holdings Corporation, Hoya Corporation, Hunan Vathin Medical Instrument Co., Ltd., Karl Storz Group, Laborie Medical Technologies, Inc., Lymol Medical Corporation, Machida Endoscope Co., Ltd., Medtronic PLC, Olympus Corporation, Richard Wolf GmbH, Roper Technologies, Inc., Teleflex Incorporated, and VBM Medizintechnik GmbH. The report provides insights on the following pointers: 1. Market Penetration: Provides comprehensive information on the market offered by the key players 2. Market Development: Provides in-depth information about lucrative emerging markets and analyze penetration across mature segments of the markets 3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments 4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players 5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments The report answers questions such as: 1. What is the market size and forecast of the Global Bronchoscopy Market? 2. What are the inhibiting factors and impact of COVID-19 shaping the Global Bronchoscopy Market during the forecast period? 3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Bronchoscopy Market? 4. What is the competitive strategic window for opportunities in the Global Bronchoscopy Market? 5. What are the technology trends and regulatory frameworks in the Global Bronchoscopy Market? 6. What is the market share of the leading vendors in the Global Bronchoscopy Market? 7. What modes and strategic moves are considered suitable for entering the Global Bronchoscopy Market? Read the full report: https://www.reportlinker.com/p06276851/?utm_source=GNW About Reportlinker ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place. __________________________

The Dow Jones rallied amid encouraging inflation data. Tesla stock jumped even as CEO Elon Musk issued a warning. Apple stock surged.

Stop investing in mediocre businesses. Buy the best, instead.

The stock market pulled back from the brink of a bear market as rate-hike expectations eased, at least for now. Here's what it will take to signal a bottom.

Markets are shaky. Your income stream doesn’t have to be.

The stock market ended its multiweek losing streak, and like a sports team that finally got a win, it’s worth celebrating. It just doesn’t mean the team—or this stock market—is any good. “Stocks finally enjoyed a strong bounce this week,” writes Canaccord Genuity analyst Martin Roberge.

Whether you're looking for household goods at discounted prices or need to buy your grocery items in bulk, Costco is the go-to retailer for millions of shoppers across the U.S. But despite its ability to attract a loyal following, Costco has made a number of changes recently that haven't thrilled customers. In April, the warehouse retailer got rid of its special COVID hours for seniors, and just this month, Costco ended its mortgage program for members. Now, the retailer has a new warning for sh

The market is unstable. Your portfolio doesn’t need to be.

Risk and reward are the yin and yang of stock trading, the two opposite but essential ingredients in every market success. And there are no stocks that better embody both sides – the risk factors and the reward potentials – than penny stocks. These equities, priced below $5 per share, typically offer high upside potentials. Even a small gain in share price – just a few cents – quickly translates into a high yield return. Of course, the risk is real, too; not every penny stock is going to show th

These two fintechs are generating strong revenue growth, but have been caught up in the market swoon.

Qualcomm CEO Cristiano Amon weighs in on the outlook for the semiconductor industry and his company's future.

Will we have enough to ‘live a simple life’ in retirement? Many other retirees wonder the same thing as you, and may be in similar financial circumstances where they’re able to pay the bills and have money saved in their retirement accounts. Your interest rate is fantastic, you’re capable of making the monthly payment from just your pension and Social Security without tapping into your 401(k) and you have so much of your home already paid off — all wins.

Julian Bridgen, co-founder and president of Macro Intelligence 2 Partners, joins Yahoo Finance Live to discuss this week's market action and whether or not it will carry over into next week, the Fed, and inflation.

Ford has been walloped. But this Wall Street firm says it has the gas to come back strong.

As of 12:24 p.m. ET, Aurora shares were still down 38.8%. At the same time, Tilray (NASDAQ: TLRY) shares were down 3.6%, and Hexo (NASDAQ: HEXO) stock was down 5.3%. The plunge in Aurora shares comes as existing shareholders react to a new round of financing that the company said will bring $150 million to the company.

Ulta shares are up after its big Q1 earnings beat, Aurora Cannabis increased its finance deal to $150 million, and Blackberry stock is surging after news of its partnership with Google.

If you have $77,280 that you can afford to invest, these stocks can turn that into $400 in recurring monthly income.

In this article, we will discuss some of the notable stocks analysts are upgrading today. To take a look at some more stocks that are being upgraded, go to Analysts Are Upgrading These 5 Stocks on Friday. The US market closed in the green for the first time in the last seven weeks as positive […]

It’s been a long slog this year for the plummeting stock market. Citigroup’s model that forecasts the chances that stocks will head into a bear market shows that the market looks like more of a buy right now.

Wood's flagship Ark Innovation ETF has fallen 52% this year as technology companies have tumbled.

The cannabis company's per-share loss was almost five times as big as analysts had expected. The stock plunged in response.